PAREXEL Announces Acquisition by Pamplona Capital for $5B - Nasdaq

Nasdaq
PAREXEL Announces Acquisition by Pamplona Capital for $5B
Nasdaq
PAREXEL International CorporationPRXL , a global biopharmaceutical services company and provider of clinical research and logistics, recently announced that it has agreed to be acquired by Pamplona Capital Management, LLP. The transaction is valued ...
Parexel acquired by Pamplona Capital - Outsourcing-Pharma.comOutSourcing-Pharma.com
Pamplona Capital Management nears deal to buy Parexel - WSJ ...Reuters
Pamplona Fund